Structure based drug design of a series of novel 1,4-benzoxazin-3-one derived PARP-1 inhibitors are described. The synthesis, enzymatic & cellular activities and pharmacodynamic effects are described. Optimized analogs demonstrated inhibition of poly-ADP-ribosylation in SW620 tumor bearing nude mice through 24h following a single dose.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2013.06.055DOI Listing

Publication Analysis

Top Keywords

discovery novel
4
novel benzo[b][14]oxazin-34h-ones
4
benzo[b][14]oxazin-34h-ones polyadp-ribosepolymerase
4
polyadp-ribosepolymerase inhibitors
4
inhibitors structure
4
structure based
4
based drug
4
drug design
4
design series
4
series novel
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!